帕金森病的睡眠问题病理生理学和药理学治疗
Cristian Falup-Pecurariu1,2, Larisa Ungureanu1,2, Iulia Murasan2
1Faculty of Medicine, Transilvania University Brasov, Romania.
Journal of Parkinson's disease
|September 2, 2025
概括
在帕金森病 (PD) 中睡眠问题很常见,影响生活质量. 了解PD睡眠障碍的机制是开发更好的治疗方法的关键.
科学领域:
- 神经学
- 睡眠医学
- 帕金森病的研究
背景情况:
- 睡眠问题是帕金森病 (PD) 的常见非运动症状.
- 这些障碍包括失眠,REM睡眠行为障碍,不安腿综合征和白天过度的嗜睡.
- 随着病情的进展,睡眠问题会恶化,影响患者的生活质量和其他症状.
研究的目的:
- 审查帕金森病的主要睡眠障碍.
- 探索病理生理学的洞察力与PD相关的睡眠障碍.
- 讨论目前和未来的治疗策略来治疗PD的睡眠障碍.
主要方法:
- 在帕金森病中睡眠障碍的文献审查.
- 拟议的病理生理机制的分析.
- 评估当前和新兴的治疗方案.
主要成果:
- 在帕金森病患者中睡眠障碍非常普遍和多样.
- 这些机制包括神经退化,神经递质功能障碍,药物副作用和昼夜节律障碍.
- 目前对PD睡眠障碍的治疗选择有限.
结论:
- 需要对病理生理机制进行进一步的研究以改善治疗点.
- 个性化管理策略对于解决帕金森病睡眠障碍至关重要.
- 开发针对PD睡眠障碍的新有效治疗方法是一个至关重要的未满足需求.
相关概念视频
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
Management of Insomnia
320
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
320
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
123
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
123
REM Sleep Behavior Disorder
387
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
387
Narcolepsy
197
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
197


